当前位置: X-MOL 学术Theranostics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Drug Repurposing Screening Identifies Tioconazole as an ATG4 Inhibitor that Suppresses Autophagy and Sensitizes Cancer Cells to Chemotherapy
Theranostics ( IF 12.4 ) Pub Date : 2018-01-01 , DOI: 10.7150/thno.22012
Pei-Feng Liu , Kun-Lin Tsai , Chien-Jen Hsu , Wei-Lun Tsai , Jin-Shiung Cheng , Hsueh-Wei Chang , Chung-Wai Shiau , Yih-Gang Goan , Ho-Hsing Tseng , Chih-Hsuan Wu , John C. Reed , Lee-Wei Yang , Chih-Wen Shu

Background: Tumor cells require proficient autophagy to meet high metabolic demands and resist chemotherapy, which suggests that reducing autophagic flux might be an attractive route for cancer therapy. However, this theory in clinical cancer research remains controversial due to the limited number of drugs that specifically inhibit autophagy-related (ATG) proteins.

中文翻译:

药物重筛选筛选确定噻康唑为ATG4抑制剂,该抑制剂可抑制自噬并能使癌细胞对化学疗法敏感。

背景:肿瘤细胞需要熟练的自噬来满足高代谢需求并抵抗化学疗法,这表明减少自噬通量可能是癌症治疗的诱人途径。但是,由于特异性抑制自噬相关蛋白(ATG)的药物数量有限,因此该理论在临床癌症研究中仍存在争议。
更新日期:2018-03-01
down
wechat
bug